Pascal Deschatelets - Net Worth and Insider Trading

Pascal Deschatelets Net Worth

The estimated net worth of Pascal Deschatelets is at least $20 Million dollars as of 2025-05-19. Pascal Deschatelets is the Chief Scientific Officer of Apellis Pharmaceuticals Inc and owns about 1,147,716 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $20 Million. Details can be seen in Pascal Deschatelets's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pascal Deschatelets has not made any transactions after 2025-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Pascal Deschatelets

To

Pascal Deschatelets Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pascal Deschatelets owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .

Click here to see the complete history of Pascal Deschatelets’s form 4 insider trades.

Insider Ownership Summary of Pascal Deschatelets

Ticker Company Transaction Date Type of Owner
APLS Apellis Pharmaceuticals Inc 2025-01-29 Chief Operating Officer

Pascal Deschatelets Latest Holdings Summary

Pascal Deschatelets currently owns a total of 1 stock. Pascal Deschatelets owns 1,147,716 shares of Apellis Pharmaceuticals Inc (APLS) as of January 29, 2025, with a value of $20 Million.

Latest Holdings of Pascal Deschatelets

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APLS Apellis Pharmaceuticals Inc 2025-01-29 1,147,716 17.45 20,027,644

Holding Weightings of Pascal Deschatelets


Pascal Deschatelets Form 4 Trading Tracker

According to the SEC Form 4 filings, Pascal Deschatelets has made a total of 33 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 33 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 826 shares on January 29, 2025, which brought Pascal Deschatelets around $24,384.

Insider Trading History of Pascal Deschatelets

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pascal Deschatelets Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pascal Deschatelets Ownership Network

Ownership Network List of Pascal Deschatelets

No Data

Ownership Network Relation of Pascal Deschatelets

Insider Network Chart


Pascal Deschatelets Owned Company Details

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Pascal Deschatelets is the Chief Operating Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , General Counsel David O. Watson , and Senior Vice President Mark Jeffrey Delong .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Pascal Deschatelets made 11 insider transaction in Apellis Pharmaceuticals Inc (APLS) with a net sale of 232,500. Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 35,769 shares made by David O. Watson , a net sale of 311,716 shares made by Cedric Francois , and a net sale of 33,815 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 5,752 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 5,752 shares. During the past 18 months, 960,256 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 960,256 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

Pascal Deschatelets Mailing Address

Above is the net worth, insider trading, and ownership report for Pascal Deschatelets. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Pascal Deschatelets's mailing address is: Crestwood Ky 40014.